Quest Diagnostics ( DGX) said it would sell $900 million worth of senior notes in a private placement to complete its acquisition of LabOne ( LABS).

The Lyndhurst, N.J., lab company said the notes will be guaranteed on a senior, unsecured basis by its domestic clinical laboratories. The company has agreed to exchange these private notes for publicly tradable notes having substantially identical terms, and will file a registration statement with the Securities and Exchange Commission. The company expects the offering will be completed by Oct. 31.

On Tuesday, Quest fell 13 cents to $46.55 and LabOne was flat at $43.85.

More from Stocks

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

Novo Nordisk Stock Rises 4% Over 2 Sessions

Novo Nordisk Stock Rises 4% Over 2 Sessions

Stock Market Just Took Another Beating -- Here's What You Need to Know

Stock Market Just Took Another Beating -- Here's What You Need to Know

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

Daimler's Profit Warning Should Terrify Traders Before Earnings Season Begins

Daimler's Profit Warning Should Terrify Traders Before Earnings Season Begins